Estradiol induces gene proximity and MLL-MLLT3 fusion in an activation-induced cytidine deaminase-mediated pathway

Leukemia and Lymphoma

Volumn 56, Issue 5, 2015, Pages 1460-1465

  Wright, Rebecca L ^a   Slemmons, Katherine K ^a   Vaughan, Andrew T M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3C; AICDA; Estradiol; IAL; MLL; MLLT3

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ESTRADIOL; HYBRID PROTEIN; MESSENGER RNA; MIXED LINEAGE LEUKEMIA PROTEIN; MLL MLLT3 FUSION PROTEIN; RNA POLYMERASE II; UNCLASSIFIED DRUG; AFF1 PROTEIN, HUMAN; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE; DNA BINDING PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; MLL PROTEIN, HUMAN; MLL-MLLT3 FUSION PROTEIN, HUMAN; MLLT3 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN BINDING;

ALLELE; ARTICLE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA CLEAVAGE; DNA DAMAGE; DNA FRAGMENTATION; EXON; GENE REARRANGEMENT; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; INTERPHASE; INTRON; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE LOCUS; GENETICS; HUMAN; METABOLISM; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CYTIDINE DEAMINASE; DNA-BINDING PROTEINS; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84932098842     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.954112     Document Type: Article

References (45)

1. Hess JL, Yu BD, Li B, et al. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 1997;90:1799-1806.
2. Rozovskaia T, Feinstein E, Mor O, et al. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality. Oncogene 2001;20:874-878.
3. Marschalek R. Mechanisms of leukemogenesis by MLL fusion proteins. Br J Haematol 2011;152:141-154.
4. Meyer C, Kowarz E, Hofmann J, et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009;23:1490-1499.
5. Meyer C, Hofmann J, Burmeister T, et al. Te MLL recombinome of acute leukemias in 2013. Leukemia 2013;27:2165-2176.
6. Emerenciano M, Meyer C, Mansur MB, et al. Te distribution of MLL breakpoints correlates with outcome in infant acute leukaemia. Br J Haematol 2013;161:224-236.
7. Pombo-de-Oliveira MS, Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 2006;15:2336-2341.
8. Chen CS, Sorensen PH, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specifc biologic variables and poor outcome. Blood 1993;81:2386-2393.
9. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993; 363:358-360.
10. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identifcation of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997;94:13950-13954.
11. Greaves M F, Maia AT, Wiemels JL, et al. Leukemia in twins: lessons in natural history. Blood 2003;102:2321-2333.
12. Spector LG, Davies SM, Robison LL, et al. Birth characteristics, maternal reproductive history, and the risk of infant leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev 2007;16:128-134.
13. Le H, Singh S, Shih SJ, et al. Rearrangements of the MLL gene are infuenced by DNA secondary structure, potentially mediated by topoisomerase II binding. Genes Chromosomes Cancer 2009;48:806-815.
14. Stanulla M, Wang J, Chervinsky DS, et al. DNA cleavage within the MLL breakpoint cluster region is a specifc event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol 1997;17:4070-4079.
15. Mirault ME, Boucher P, Tremblay A. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot. Am J Hum Genet 2006;79:779-791.
16. Huret JL, Dessen P, Bernheim A. An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners. Leukemia 2001;15:987-989.
17. Meyer C, Schneider B, Jakob S, et al. Te MLL recombinome of acute leukemias. Leukemia 2006;20:777-784.
18. Schnyder S, Du NT, Le HB, et al. Estrogen treatment induces MLL aberrations in human lymphoblastoid cells. Leuk Res 2009; 33:1400-1404.
19. Scharf S, Zech J, Bursen A, et al. Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene. Oncogene 2007;26:1361-1371.
20. Lin C, Yang L, Tanasa B, et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specifc translocations in cancer. Cell 2009;139:1069-1083.
21. Hagege H, Klous P, Braem C, et al. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2007;2:1722-1733.
22. Gue M, Sun JS, Boudier T. Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited. BMC Cancer 2006;6:20.
23. Cowell IG, Sondka Z, Smith K, et al. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIbeta-mediated DNA strand breaks and gene proximity. Proc Natl Acad Sci USA 2012;109:8989-8994.
24. Nam DK, Honoki K, Yu M, et al. Alternative RNA splicing of the MLL gene in normal and malignant cells. Gene 1996;178: 169-175.
25. Super HJ, Martinez-Climent J, Rowley JD. Molecular analysis of the Mono Mac 6 cell line: detection of an MLL-AF9 fusion transcript. Blood 1995;85:855-856.
26. Robbiani DF, Bothmer A, Callen E, et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008;135:1028-1038.
27. Greisman HA, Lu Z, Tsai AG, et al. IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas. Blood 2012;120:2864-2867.
28. Selsing E. Ig class switching: targeting the recombinational mechanism. Curr Opin Immunol 2006;18:249-254.
29. Robbiani DF, Bunting S, Feldhahn N, et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell 2009;36:631-641.
30. Xu Z, Pone EJ, Al-Qahtani A, et al. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 2007;27:367-397.
31. Maul RW, Gearhart PJ. AID and somatic hypermutation. Adv Immunol 2010;105:159-191.
32. Shih SJ, Fass J, Bufalo V, et al. Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy. Br J Haematol 2012;159:50-57.
33. Schmitz KM, Petersen-Mahrt SK. AIDing the immune system-DIAbolic in cancer. Semin Immunol 2012;24:241-245.
34. Pavri R, Gazumyan A, Jankovic M, et al. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 2010;143:122-133.
35. Pham P, Bransteitter R, Petruska J, et al. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003;424:103-107.
36. Shen HM, Poirier MG, Allen MJ, et al. Te activation-induced cytidine deaminase (AID) efciently targets DNA in nucleosomes but only during transcription. J Exp Med 2009;206:1057-1071.
37. Jung R, Jacobs U, Krumbholz M, et al. Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment. Leukemia 2010;24:903-907.
38. Barjesteh van Waalwijk van Doorn-Khosrovani S, Janssen J, Maas LM, et al. Dietary favonoids induce MLL translocations in primary human CD34 + cells. Carcinogenesis 2007;28:1703-1709.
39. Spector LG, Xie Y, Robison LL, et al. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev 2005;14:651-655.
40. Brassesco MS, Montaldi AP, Gras DE, et al. MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals. Genet Mol Biol 2009;32:234-241.
41. Schnittger S, Wormann B, Hiddemann W, et al. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998;92:1728-1734.
42. Basecke J, Podleschny M, Clemens R, et al. Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults. Leuk Res 2006;30:1091-1096.
43. Basecke J, Griesinger F, Trumper L, et al. Leukemia-and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol 2002;81:64-75.
44. Mori H, Colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002;99:8242-8247.
45. Summers KE, Gof LK, Wilson AG, et al. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 2001;19:420-424.